In , 싸토리우스 is centrally located with a picturesque view of the Umeälven river
Attwoof 싸토리우스’ most Northern sites,in Umeåand Malmö, data analytics experts developsome of theworld’sleadingdata-based software solutionsfor the life sciences and the biopharma industry. Their ambition: To create insights from data that helpreducethe timeline forthe development and manufacture ofnew drugs or vaccines.
Editor's note: This 게시물 dates from 2021; the is now part of the Product Group Digital Solutions which works on advancing the development of software-based products and applications in the Bioprocess Solutions Division.
This article is posted on Sartorius Blog.
“Our goal at 싸토리우스 is to help customers to bring novel medications to market faster,” Andreas Norén, Head of Quality at 싸토리우스 Stedim Data Analytics, explains. “Data can play a decisive role along the whole process chain for a biopharmaceutical drug.” At 싸토리우스 in Sweden, a team of data scientists and software specialists are working on world-leading software solutions for this challenge. Learn more about Umetrics® Suite
®
Andreas Norén, Head of Quality at 싸토리우스 Stedim Data Analytics and alumni of UmeåUniversity
A look back: In1987, five years after thefirstbiopharmaceutical drug wasapproved for therapeutic use, Umetrics,wasfounded.Thirty years later, 싸토리우스 acquiredthe thenleading specialistindata analytics software for biopharma processes. Operating as 싸토리우스 Stedim Data Analytics,today,the company is home to more than 80employeesinUmeåand Malmö.
And it is on the move. AnnikaFinck, Head of Development at 싸토리우스 Data Analytics joined the company in 2020. After studying computer science, she advanced her career in project and program management, before moving from Malmö to Umeå to lead the company’s transformation towards cloud solutions.
“It’s an exciting time – and a challenging one. Wehavecreated an agile “DevOps” culture within thecompany,and we are working with 빅데이터, Artificial Intelligence, Kubernetes, event driven target architecture and other pioneering methods and technologies. All with the ambition to bring 30 years of software product development from desktop solutions to a cloud-based, regulatory-compliant, data analytics platform that empowers our customers to create affordable and safe products.”
The Umetrics Suite helps scientists and engineers to create useful information out of data in labs and on product floors
With ambitious tasks ahead, the organizational structure must lead the way. “We have 규명된 a new team structure, recruited line managers and are expecting to significantly grow the team in the next two years,”Annikasays. Currently,싸토리우스hasseveral vacancies in data analytics and software development in Sweden- and hundreds of open positions worldwide. “We areone of the fastest-growing global life science companies, doublingour revenue every five years toan expected 5billion in 2025”, she concludes. “This offers the chance to grow along with the company.” Andreas, whostartedhis career with Umetrics in 2003 whenhewas still at university, adds:"Ever since I joined the company, I havehad the chance to develop – personally and professionally.With thetransformations ahead, this will continue to be a place where people can bring in their skills, thrive and – at the same time.”
Career: Join Our Global Team
More Jobs With 싸토리우스 Data Analytics
Software experts, data scientists, IT specialists - learn more about how digital experts make an impact at 싸토리우스
At 싸토리우스, software development experts work on programs that automate processes in drug manufacturing – helping to bring medicine to patients worldwide faster. This makes them part of the solution...
To understand how 싸토리우스 drives innovation, we have initiated a series of interviews with Dr. Oscar-Werner Reif, Head of Corporate Research and Chief Technology Officer.
Svea Cheeseman and Stefanie Metzig share why they chose to study science and how they found their way in a male-dominated environment.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
If you have open questions, please contact our Media Relations team.